JP2010503624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010503624A5 JP2010503624A5 JP2009527719A JP2009527719A JP2010503624A5 JP 2010503624 A5 JP2010503624 A5 JP 2010503624A5 JP 2009527719 A JP2009527719 A JP 2009527719A JP 2009527719 A JP2009527719 A JP 2009527719A JP 2010503624 A5 JP2010503624 A5 JP 2010503624A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- unsubstituted
- het
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 amino, aminomethylene, amidino, guanidino, azetidinyl Chemical group 0.000 claims 36
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 3
- GRMNJXQBRPJVQV-UHFFFAOYSA-N 2,3-dihydroxybutanediamide Chemical compound NC(=O)C(O)C(O)C(N)=O GRMNJXQBRPJVQV-UHFFFAOYSA-N 0.000 claims 3
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000001786 isothiazolyl group Chemical group 0.000 claims 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000000160 oxazolidinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- YCKAPACJTUULKL-HUUCEWRRSA-N (2r,3r)-n-(4-carbamimidoylphenyl)-2,3-dihydroxy-n'-(4-methylphenyl)butanediamide Chemical compound C1=CC(C)=CC=C1NC(=O)[C@H](O)[C@@H](O)C(=O)NC1=CC=C(C(N)=N)C=C1 YCKAPACJTUULKL-HUUCEWRRSA-N 0.000 claims 1
- RHQRJMRBDPUWQG-HZPDHXFCSA-N (2r,3r)-n-[4-(aminomethyl)phenyl]-2,3-dihydroxy-n'-(4-methylphenyl)butanediamide Chemical compound C1=CC(C)=CC=C1NC(=O)[C@H](O)[C@@H](O)C(=O)NC1=CC=C(CN)C=C1 RHQRJMRBDPUWQG-HZPDHXFCSA-N 0.000 claims 1
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 claims 1
- 125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 claims 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 claims 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims 1
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 claims 1
- 125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 claims 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 claims 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 claims 1
- 125000005955 1H-indazolyl group Chemical group 0.000 claims 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 claims 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 125000002785 azepinyl group Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000003943 azolyl group Chemical group 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims 1
- 125000004623 carbolinyl group Chemical group 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 claims 1
- 125000004856 decahydroquinolinyl group Chemical group N1(CCCC2CCCCC12)* 0.000 claims 1
- 125000005509 dibenzothiophenyl group Chemical group 0.000 claims 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 claims 1
- 125000000532 dioxanyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000003838 furazanyl group Chemical group 0.000 claims 1
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 1
- 125000002636 imidazolinyl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 claims 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 claims 1
- 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 claims 1
- 125000005438 isoindazolyl group Chemical group 0.000 claims 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 claims 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims 1
- 125000004930 octahydroisoquinolinyl group Chemical group C1(NCCC2CCCC=C12)* 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 claims 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 claims 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 claims 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 claims 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 claims 1
- 125000004932 phenoxathinyl group Chemical group 0.000 claims 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 claims 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 claims 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims 1
- 125000002755 pyrazolinyl group Chemical group 0.000 claims 1
- 125000001422 pyrrolinyl group Chemical group 0.000 claims 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 claims 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- 125000004306 triazinyl group Chemical group 0.000 claims 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 claims 1
- 125000004933 β-carbolinyl group Chemical group C1(=NC=CC=2C3=CC=CC=C3NC12)* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006042927 | 2006-09-13 | ||
| DE102006042927.3 | 2006-09-13 | ||
| PCT/EP2007/007612 WO2008031508A1 (de) | 2006-09-13 | 2007-08-31 | Tartratderivate als inhibitoren des koagulationsfaktors ixa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010503624A JP2010503624A (ja) | 2010-02-04 |
| JP2010503624A5 true JP2010503624A5 (enExample) | 2010-09-30 |
| JP5249225B2 JP5249225B2 (ja) | 2013-07-31 |
Family
ID=38720737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009527719A Expired - Fee Related JP5249225B2 (ja) | 2006-09-13 | 2007-08-31 | 凝固第ＩＸａ因子インヒビターとしての使用のための酒石酸誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8263621B2 (enExample) |
| EP (1) | EP2069288B1 (enExample) |
| JP (1) | JP5249225B2 (enExample) |
| KR (1) | KR20090053813A (enExample) |
| CN (1) | CN101516833B (enExample) |
| AR (1) | AR062744A1 (enExample) |
| AU (1) | AU2007297012B2 (enExample) |
| BR (1) | BRPI0716778A2 (enExample) |
| CA (1) | CA2663543A1 (enExample) |
| CL (1) | CL2007002651A1 (enExample) |
| CO (1) | CO6220943A2 (enExample) |
| IL (1) | IL197505A0 (enExample) |
| MA (1) | MA30706B1 (enExample) |
| MX (1) | MX2009001990A (enExample) |
| MY (1) | MY148254A (enExample) |
| NO (1) | NO20091106L (enExample) |
| NZ (1) | NZ575604A (enExample) |
| RU (1) | RU2446160C2 (enExample) |
| TW (1) | TWI406852B (enExample) |
| UY (1) | UY30586A1 (enExample) |
| WO (1) | WO2008031508A1 (enExample) |
| ZA (1) | ZA200900806B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209976B (zh) * | 2006-12-29 | 2012-01-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 取代的酒石酸衍生物及其用于制备β-分泌酶抑制剂的用途 |
| CA2745121A1 (en) | 2008-12-05 | 2010-06-10 | Mochida Pharmaceutical Co., Ltd. | Morpholinone compounds as factor ixa inhibitors |
| US8987242B2 (en) | 2008-12-05 | 2015-03-24 | Merck Sharp & Dohme Corp. | Morpholinone compounds as factor IXA inhibitors |
| CN102753555B (zh) * | 2010-02-11 | 2018-01-12 | 百时美施贵宝公司 | 作为因子xia抑制剂的大环类 |
| WO2015160636A1 (en) | 2014-04-16 | 2015-10-22 | Merck Sharp & Dohme Corp. | Factor ixa inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3731542A1 (de) * | 1987-09-17 | 1989-03-30 | Schering Ag | Neue dicarbonsaeure-bis(3,5-dicarbamoyl-2,4,6-triiod-anilide), verfahren zu deren herstellung sowie diese enthaltende roentgenkontrastmittel |
| RU2043344C1 (ru) * | 1991-05-20 | 1995-09-10 | Курский Государственный Медицинский Институт | N-2-(1- r1-5-r2-6-r3- бензимидазолил)сукцинаминовые кислоты, проявляющие нейролептическую, антигипоксическую и антиаритмическую активность |
| EP0691976A1 (en) | 1993-03-29 | 1996-01-17 | Queen's University At Kingston | Anticoagulant compounds |
| CA2428191A1 (en) | 2000-11-07 | 2002-05-30 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
| US20020151595A1 (en) | 2001-02-02 | 2002-10-17 | Ries Uwe Joerg | Carboxylic acid amides having antithrombotic activity |
| DE10104598A1 (de) * | 2001-02-02 | 2002-08-08 | Boehringer Ingelheim Pharma | Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
| US7122559B2 (en) | 2003-02-11 | 2006-10-17 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| US7638513B2 (en) * | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
-
2007
- 2007-08-31 WO PCT/EP2007/007612 patent/WO2008031508A1/de not_active Ceased
- 2007-08-31 AU AU2007297012A patent/AU2007297012B2/en not_active Ceased
- 2007-08-31 MY MYPI20090508A patent/MY148254A/en unknown
- 2007-08-31 CA CA002663543A patent/CA2663543A1/en not_active Abandoned
- 2007-08-31 NZ NZ575604A patent/NZ575604A/en not_active IP Right Cessation
- 2007-08-31 BR BRPI0716778-4A2A patent/BRPI0716778A2/pt not_active IP Right Cessation
- 2007-08-31 CN CN2007800339733A patent/CN101516833B/zh not_active Expired - Fee Related
- 2007-08-31 KR KR1020097005182A patent/KR20090053813A/ko not_active Ceased
- 2007-08-31 EP EP07802030.2A patent/EP2069288B1/de active Active
- 2007-08-31 MX MX2009001990A patent/MX2009001990A/es active IP Right Grant
- 2007-08-31 RU RU2009113616/04A patent/RU2446160C2/ru not_active IP Right Cessation
- 2007-08-31 JP JP2009527719A patent/JP5249225B2/ja not_active Expired - Fee Related
- 2007-09-11 UY UY30586A patent/UY30586A1/es not_active Application Discontinuation
- 2007-09-11 TW TW096133789A patent/TWI406852B/zh not_active IP Right Cessation
- 2007-09-11 AR ARP070104011A patent/AR062744A1/es not_active Application Discontinuation
- 2007-09-12 CL CL200702651A patent/CL2007002651A1/es unknown
-
2009
- 2009-02-03 ZA ZA2009/00806A patent/ZA200900806B/en unknown
- 2009-03-04 CO CO09022192A patent/CO6220943A2/es not_active Application Discontinuation
- 2009-03-06 MA MA31699A patent/MA30706B1/fr unknown
- 2009-03-09 IL IL197505A patent/IL197505A0/en unknown
- 2009-03-09 US US12/400,187 patent/US8263621B2/en not_active Expired - Fee Related
- 2009-03-16 NO NO20091106A patent/NO20091106L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010503625A5 (enExample) | ||
| JP2010503624A5 (enExample) | ||
| ES2930157T3 (es) | Combinación que comprende un inhibidor de MEK y un inhibidor de B-Raf | |
| BR112020018209A2 (pt) | Composições farmacêuticas, recipiente pressurizado, e, métodos para tratar ou prevenir uma infecção viral e para tratar ou prevenir um coronavírus humano, coronavírus sars, coronavírus mers, vírus da encefalite equina oriental, vírus da encefalite equina ocidental, vírus da encefalite equina venezuelana, vírus da chicungunha, vírus ross river, rsv, vírus influenza a, vírus influenza b, vírus tacaribe, vírus pichinde, vírus junin, vírus da febre lassa, vírus da cariomeningite linfocitária, vírus da febre rift valley, vírus punta toro, vírus lacrosse, vírus maporal, vírus heartland, e vírus da síndrome de trombocitopenia de febre severa, poliovírus, vírus de coxsackie, infecção de norovírus ou enterovírus em um paciente | |
| ES2673973T3 (es) | Inhibidores de tirosina cinasa de Bruton | |
| JP2009509989A5 (enExample) | ||
| RU2013147744A (ru) | Дозированная лекарственная форма для перорального применения | |
| JP2019515908A5 (enExample) | ||
| JP2008500390A5 (enExample) | ||
| WO2012037298A1 (en) | Fatty acid synthase inhibitors | |
| JP2018506531A5 (enExample) | ||
| JP6100700B2 (ja) | 組合せ | |
| JP2008519833A5 (enExample) | ||
| RU2009113602A (ru) | Изосериновые производные для применения в качестве ингибиторов фактора свертывания крови ixa | |
| AR070441A1 (es) | Clorotiofeno - amidas como inhibidores de los factores de coagulacion xa y trombina | |
| JP2006528941A5 (enExample) | ||
| RU2015134148A (ru) | Галеновая форма для введения активного действующего вещества | |
| BR112019017962A2 (pt) | método para inibição de crescimento, de migração, de proliferação e/ou de metástase de uma célula pré-cancerosa, cancerosa ou neoplásica ou de inibição de um patógeno, composição probiótica tópica, bandagem ou curativo, método de tratamento de dano na pele devido à radiação uv, e, composição farmacêutica | |
| AR045683A1 (es) | Derivados de bencimidazol como inhibidores del factor xa | |
| RU2009113616A (ru) | Тартратные производные для применения в качестве ингибиторов фактора свертывания крови ixa | |
| US10308937B2 (en) | Combination long acting compositions and methods for Hepatitis C | |
| JP2011520934A (ja) | 筋ジストロフィー治療用化合物 | |
| AU2015344740A1 (en) | Long acting pharmaceutical compositions for Hepatitis C | |
| JP2008542315A5 (enExample) | ||
| ES2544542T3 (es) | Derivados de la acadesina, productos y composiciones que los comprenden, sus utilizaciones terapéuticas y sus procedimientos de síntesis |